Hims & Hers Health, INC Form 4 insider transactions

Chief Legal Officer Soleil Boughton sold 9,463 shares of Hims & Hers Health, Inc. stock via a 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe exercised stock options and sold shares under a pre-established Rule 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe sold shares of Hims & Hers Health, Inc. under a pre-established Rule 10b5-1 trading plan.

Andrew Dudum, CEO of Hims & Hers Health, Inc., reported a transfer of 422,933 shares of Class A Common Stock to the Dudum Family Community Property Trust on April 9, 2026.

Hims & Hers Health, Inc. Chief Financial Officer, Oluyemi Okupe, executed a stock option exercise and subsequent sale of shares under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health, Inc. CFO Oluyemi Okupe executed a pre-planned stock option exercise and subsequent sale of Class A Common Stock.

Irene Becklund, Principal Accounting Officer of Hims & Hers Health, Inc., sold 5,529 shares of Class A Common Stock for $24.69 per share under a pre-arranged trading plan.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, sold 4,812 shares of Class A Common Stock for $24.69 per share under a pre-arranged trading plan.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi sold 97,289 shares of Class A Common Stock for $24.69 per share pursuant to a pre-arranged trading plan.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported the vesting and settlement of Restricted Stock Units and associated tax withholdings.

Hims & Hers Health, Inc. Director Christiane Pendarvis acquired 15,211 shares of Class A Common Stock through the vesting of Restricted Stock Units.

Hims & Hers Health, Inc. Chief Medical Officer Patrick Harrison Carroll reported the vesting of 16,522 restricted stock units and the withholding of 4,022 shares for tax obligations.

A Hims & Hers Health, Inc. Chief Policy Officer and Director acquired shares through RSU vesting and sold a portion to cover tax obligations.

Irene Becklund, Principal Accounting Officer of Hims & Hers Health, Inc., reported the vesting of Restricted Stock Units and subsequent tax-related share disposals.

Hims & Hers Health, Inc. CEO Andrew Dudum reported the vesting and settlement of restricted stock units and associated tax withholdings of Class A Common Stock.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, reported the vesting and tax-related disposition of Class A Common Stock and Restricted Stock Units.

Hims & Hers Health, Inc. CFO Oluyemi Okupe reported routine equity transactions, including RSU vesting and shares withheld for tax obligations.

Hims & Hers Health, Inc. disclosed a grant of 62,076 Restricted Stock Units to Principal Accounting Officer Irene Becklund, vesting over four years.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi was granted 376,222 Restricted Stock Units, vesting over four years.

Hims & Hers Health, Inc. has granted 526,711 Restricted Stock Units to Chief Policy Officer Deborah M. Autor, vesting over four years.

Hims & Hers Health, Inc. Director and Chief Medical Officer Patrick Harrison Carroll was granted 150,489 Restricted Stock Units, vesting over four years.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, was granted 188,111 Restricted Stock Units subject to a four-year service-based vesting schedule.

Hims & Hers Health, Inc. CTO Mohamed Elshenawy was granted 376,222 Restricted Stock Units, vesting over four years.

Hims & Hers Health, Inc. CEO Andrew Dudum was granted 413,844 Restricted Stock Units, vesting over four years starting June 2026.

Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe was granted 300,978 Restricted Stock Units, vesting over four years.

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, earned 410,690 shares of Class A Common Stock through performance-based restricted stock units.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, earned 273,794 shares of Class A common stock through performance-based restricted stock units.

Hims & Hers Health, Inc.'s Chief Operating Officer, Michael Chi, earned 365,058 performance-based restricted stock units, reflecting met performance criteria.

Hims & Hers Health, Inc. CEO Andrew Dudum acquired 794,002 Class A common shares after performance criteria for restricted stock units were met.

Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options and immediately sold an equal number of Class A Common Stock shares under a pre-arranged 10b5-1 trading plan.